Literature DB >> 8305147

A case of primary hepatic actinomycosis.

J D Lee1, P G Kim, H J Jo, D H Park, E J Seo.   

Abstract

Actinomycosis is a chronic suppurative and granulomatous disease characterized histologically by sulfur granules with extensive necrosis, fibrosis and sinus formation. Depending on the site of primary infection, actinomycosis is generally classified as cervicofacial, thoracic and abdominal type. The liver is known to be the primary site of infection in 15% with abdominal actinomycosis. The authors have experienced a case of liver abscess in a 24-year-old male. The sono-guided aspiration biopsy revealed findings of infiltration of neutrophils and characteristics sulfur granules by light microscopy. This case was thought to represent an instance of liver actinomycosis. Although there have been a lot of reports on actinomycosis of the liver in other countries, only 3 cases were reported in Korea.

Entities:  

Mesh:

Year:  1993        PMID: 8305147      PMCID: PMC3053711          DOI: 10.3346/jkms.1993.8.5.385

Source DB:  PubMed          Journal:  J Korean Med Sci        ISSN: 1011-8934            Impact factor:   2.153


  4 in total

1.  Hepatic actinomycosis mimicking an isolated tumor recurrence.

Authors:  Michael G Wayne; Rahul Narang; Arif Chauhdry; Justin Steele
Journal:  World J Surg Oncol       Date:  2011-07-11       Impact factor: 2.754

2.  A case of primary hepatic actinomycosis: an enigmatic inflammatory lesion of the liver.

Authors:  Yeon Jung Ha; Ji Hyun An; Ju Hyun Shim; Eun Sil Yu; Jong Jae Kim; Tae Yong Ha; Han Chu Lee
Journal:  Clin Mol Hepatol       Date:  2015-03-25

Review 3.  A systematic review of case reports of hepatic actinomycosis.

Authors:  Zahra Chegini; Mojtaba Didehdar; Seidamir Pasha Tabaeian; Amin Khoshbayan; Aref Shariati
Journal:  Orphanet J Rare Dis       Date:  2021-04-30       Impact factor: 4.123

4.  Hepatic actinomycosis with immunoglobulin G4-related liver disease: A case report.

Authors:  Joo Hyung Lee; Hyung Sun Kim; Ji Sub Kim; Dong Ki Lee; Jin Hong Lim
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.